Aspergillus Bronchitis in Cystic Fibrosis

      Aspergillus fumigatus, a widely distributed spore-bearing fungus, is commonly grown in sputum cultures of patients with cystic fibrosis (CF). A fumigatus

      may cause allergic bronchopulmonary aspergillosis (ABPA), a complex condition that leads to worsening of airway inflammation and progressive damage and is diagnosed by specific criteria. In this report, we present six CF patients with respiratory deterioration that did not respond to appropriate antibiotic treatment. All had had A fumigatus in sputum cultures but did not fulfill the criteria of ABPA. Treatment with antifungal agents was followed by improvement in clinical condition. We suggest that in patients with CF, A fumigatus should be considered as a pathogen that may directly cause respiratory exacerbations. Antifungal therapy should be considered when deteriorating respiratory function is not responding to antibacterial therapy and A fumigatus is growing in sputum cultures.

      Key words

      Abbreviations:

      ABPA ( allergic bronchopulmonary aspergillosis), CF ( cystic fibrosis), ESR ( erythrocytes sedimentation rate)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stevens DA
        • Moss RB
        • Kurup VP
        • et al.
        Allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art; Cystic Fibrosis Foundation Consensus Conference.
        Clin Infect Dis. 2003; 37: S225-S264
        • Knutsen A
        • Slavin RG
        Allergic bronchopulmonary mycosis complicating cystic fibrosis.
        Semin Respir Infect. 1992; 7: 179-192
        • Hutcheson PS
        • Knutsen AP
        • Rejent AJ
        • et al.
        A 12-year longitudinal study of Aspergillus sensitivity in cystic fibrosis patients.
        Chest. 1996; 110: 363-366
        • Brasfield D
        • Hicks G
        • Soong S
        • et al.
        Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study.
        AJR Am J Roentgenol. 1980; 134: 1195-1198
        • Bhalla M
        • Turcios N
        • Aponte V
        • et al.
        Cystic fibrosis: scoring system with thin-section CT.
        Radiology. 1991; 179: 783-788
        • Geller DE
        • Kaplowitz H
        • Light MJ
        • et al.
        Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
        Chest. 1999; 116: 639-646
        • Greenberger PA
        • Patterson R
        Diagnosis and management of allergic bronchopulmonary aspergillosis.
        Ann Allergy. 1986; 56: 444-452
        • Banerjee B
        • Kurup VP
        • Greenberger PA
        • et al.
        Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus.
        J Allergy Clin Immunol. 1997; 99: 821-827
        • Moss RB
        Pathophysiology and immunology of allergic bronchopulmonary aspergillosis.
        Med Mycol. 2005; 43: S203-S206
        • Laufer P
        • Fink JN
        • Burns WT
        • et al.
        Allergic bronchopulmonary aspergillosis in cystic fibrosis.
        J Allergy Clin Immunol. 1984; 73: 44-48
        • Mastella G
        • Rainisio M
        • Harms HK
        • et al.
        Allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study.
        Eur Respir J. 2000; 16: 464-471
        • Mehrad B
        • Paciocco G
        • Martinez FJ
        • et al.
        Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature.
        Chest. 2001; 119: 169-175
        • Denning DW
        • Follansbee SE
        • Scolaro M
        • et al.
        Pulmonary aspergillosis in the acquired immunodeficiency syndrome.
        N Engl J Med. 1991; 324: 654-662
        • Caputo R
        Itraconazole (Sporanox) in superficial and systemic fungal infections.
        Expert Rev Anti Infect Ther. 2003; 1: 531-542
        • Conway SP
        • Etherington C
        • Peckham DG
        • et al.
        Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.
        J Antimicrob Chemother. 2004; 53: 841-847
        • Conway SP
        • Etherington C
        • Peckham DG
        • et al.
        Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.
        J Antimicrob Chemother. 2004; 53: 841-847
        • Herbrecht R
        • Nivoix Y
        • Fohrer C
        • et al.
        Management of systemic fungal infections: alternatives to itraconazole.
        J Antimicrob Chemother. 2005; 56: i39-i48
        • Mussaffi H
        • Rivlin J
        • Shalit I
        • et al.
        Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.
        Eur Respir J. 2005; 25: 324-328